In support of Yuan et al., we recently identified a gene signature associated with poorer survival for patients with EGFR-mutated adenocarcinomas, where the high-risk patient group showed more copy number gains and amplifications on chromosome 7p [46]. The gene discussed is EGFR; the disease is adenocarcinoma.